Ex parte MURRER et al. - Page 17




                     Appeal No. 95-2603                                                                                                                                                
                     Application 07/915,871                                                                                                                                            


                     23.  Otherwise, we believe that it is unlikely Barefield would                                                                                                    
                     have made a positive scientific assertion that his Compound 2                                                                                                     
                     "is very insoluble in water ***" (page 303, first footnote).                                                                                                      
                     In this regard, we point out that the language of appealed                                                                                                        
                     claim 23 merely calls for a “pharmaceutically acceptable                                                                                                          
                     carrier”.  Water is a known pharmaceutically acceptable                                                                                                           
                     carrier  and thus the mixture of water and bicyclam of10                                                                                                                                                 
                     Barefield meets all the limitations of claims 7 and 23 (i.e.,                                                                                                     
                     these claims on appeal do not require that the active                                                                                                             
                     ingredient is soluble in the carrier).                                                                                                                            
                                Claim 23 is rejected under 35 U.S.C. § 112, first                                                                                                      
                     paragraph, as lacking enablement as to how to make the claimed                                                                                                    
                     active ingredients in view of Ciampolini.  Claim 23 lists                                                                                                         
                     active ingredients with 2 to 6 carbon atom chains as linking                                                                                                      
                     groups between the cyclam rings.  Appellants’ only enablement                                                                                                     
                     regarding “how to make” is the disclosure that “[A] number of                                                                                                     
                     the active ingredients according to the invention are known,                                                                                                      
                     and the compounds may be prepared by identical methods or                                                                                                         
                     methods analogous thereto.” (specification, page 4).                                                                                                              


                                10    Ibid.                                                                                                                                            
                                                                                         17                                                                                            





Page:  Previous  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  Next 

Last modified: November 3, 2007